Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer
Journal of Cancer Research and Clinical Oncology · 2024
DOI: 10.1007/s00432-024-05971-4 ↗At a glance
Journal article in Journal of Cancer Research and Clinical Oncology, 2024. Written by Liping Yang and 9 co-authors. Institution: PET-CT/MR Department, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Chemoradiotherapy, Tomography, X-Ray Computed. Cited 2 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Hai Yan Fund of The Third Affiliated Hospital of Harbin Medical University, National Natural Science Foundation of China, National Undergraduate Innovation and Entrepreneurship Training Program.
Abstract (original language)
Kokkuvõte pole saadaval.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- PET-CT/MR Department, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China.
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, People's Republic of China.
- Department of Equipment, The Second Hospital of Harbin, Harbin, People's Republic of China.
- Department of Physical Diagnosis, Heilongjiang Provincial Hospital, Harbin, People's Republic of China.
- Department of Thoracic Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, 150001, People's Republic of China. liushilong1984@hrbmu.edu.cn.
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150001, People's Republic of China. qilishuang7@ems.hrbmu.edu.cn.
Funding
- Hai Yan Fund of The Third Affiliated Hospital of Harbin Medical University
- National Natural Science Foundation of China
- National Undergraduate Innovation and Entrepreneurship Training Program
- Provincial Key Research and Development Program of Heilongjiang Province
Cite
APA
Yang, L., Li, M., Liu, Y., Jiang, Z., Xu, S., Ding, H., Gao, X., Liu, S., Qi, L., & Wang, K. (2024). Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05971-4
Vancouver
Yang L, Li M, Liu Y, Jiang Z, Xu S, Ding H, et al. Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05971-4
BibTeX
@article{Yang2024,
author = {Yang, Liping and Li, Mengyue and Liu, Yixin and Jiang, Zhiyun and Xu, Shichuan and Ding, Hongchao and Gao, Xing and Liu, Shilong and Qi, Lishuang and Wang, Kezheng},
title = {Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer},
journal = {Journal of Cancer Research and Clinical Oncology},
year = {2024},
doi = {10.1007/s00432-024-05971-4}
}
EUVIMED